Immunotherapy Company 3D Medicines Raises Funds After Spin-Off
October 10, 2020 — 03:01 CST
This Data Is Locked!
This area is available only to Subscribers.
3D Medicines, a tumor immunotherapy company, has recently completed the first round of financing after a US$140 million spin-off, which is approximately RMB970 million yuan.... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals